PL365794A1 - Analiza ekspresji kwasów nukleinowych i polipeptydów inhibitora różnicowania użytecznych w diagnostyce i leczeniu raka prostaty - Google Patents

Analiza ekspresji kwasów nukleinowych i polipeptydów inhibitora różnicowania użytecznych w diagnostyce i leczeniu raka prostaty

Info

Publication number
PL365794A1
PL365794A1 PL01365794A PL36579401A PL365794A1 PL 365794 A1 PL365794 A1 PL 365794A1 PL 01365794 A PL01365794 A PL 01365794A PL 36579401 A PL36579401 A PL 36579401A PL 365794 A1 PL365794 A1 PL 365794A1
Authority
PL
Poland
Prior art keywords
diagnosis
inhibitor
treatment
nucleic acids
prostate cancer
Prior art date
Application number
PL01365794A
Other languages
English (en)
Inventor
Kimberly A. Gillis
Yixian Zhang
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth filed Critical Wyeth
Publication of PL365794A1 publication Critical patent/PL365794A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL01365794A 2000-11-28 2001-11-28 Analiza ekspresji kwasów nukleinowych i polipeptydów inhibitora różnicowania użytecznych w diagnostyce i leczeniu raka prostaty PL365794A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25337400P 2000-11-28 2000-11-28

Publications (1)

Publication Number Publication Date
PL365794A1 true PL365794A1 (pl) 2005-01-10

Family

ID=22959998

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365794A PL365794A1 (pl) 2000-11-28 2001-11-28 Analiza ekspresji kwasów nukleinowych i polipeptydów inhibitora różnicowania użytecznych w diagnostyce i leczeniu raka prostaty

Country Status (14)

Country Link
US (1) US20020182614A1 (pl)
EP (1) EP1356107A2 (pl)
JP (1) JP2004526424A (pl)
AU (1) AU2002239363A1 (pl)
BR (1) BR0115689A (pl)
CA (1) CA2429721A1 (pl)
HU (1) HUP0303890A3 (pl)
IL (1) IL155953A0 (pl)
MX (1) MXPA03004577A (pl)
NO (1) NO20032393L (pl)
NZ (1) NZ526706A (pl)
PL (1) PL365794A1 (pl)
WO (1) WO2002044417A2 (pl)
ZA (1) ZA200304997B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022858A1 (en) * 2000-09-14 2002-03-21 The Regents Of The University Of California Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma
CA2505416A1 (en) * 2002-11-21 2004-06-10 Wyeth Methods for diagnosing rcc and other solid tumors
US7643943B2 (en) 2003-02-11 2010-01-05 Wyeth Llc Methods for monitoring drug activities in vivo
AU2004235395A1 (en) * 2003-04-29 2004-11-11 Wyeth Methods for prognosis and treatment of solid tumors
AU2004273034A1 (en) * 2003-09-05 2005-03-24 Sanofi Pasteur Limited Multi-antigen vectors for melanoma
EP2674435A3 (en) 2006-03-24 2014-04-30 Phenomenome Discoveries Inc. Biomarkers useful for diagnosing prostate cancer, and methods thereof
KR102881803B1 (ko) * 2021-03-08 2025-11-12 (주)아큐레시스바이오 췌장암의 진단용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6591396A (en) * 1995-08-01 1997-02-26 Sloan-Kettering Institute For Cancer Research Id as a diagnostic marker in tumor cells
AU2024799A (en) * 1998-01-09 1999-07-26 President And Fellows Of Harvard College Immortalization of primary human keratinocytes by the helix-loop-helix protein, id-1
EP1047793B1 (en) * 1998-01-21 2006-11-15 Dianon Systems, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
WO2002022858A1 (en) * 2000-09-14 2002-03-21 The Regents Of The University Of California Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma

Also Published As

Publication number Publication date
BR0115689A (pt) 2004-02-10
WO2002044417A3 (en) 2003-07-24
AU2002239363A1 (en) 2002-06-11
US20020182614A1 (en) 2002-12-05
JP2004526424A (ja) 2004-09-02
MXPA03004577A (es) 2003-09-04
WO2002044417A9 (en) 2003-11-20
NZ526706A (en) 2005-03-24
IL155953A0 (en) 2003-12-23
NO20032393L (no) 2003-07-03
NO20032393D0 (no) 2003-05-27
CA2429721A1 (en) 2002-06-06
HUP0303890A3 (en) 2006-03-28
HUP0303890A2 (hu) 2004-03-01
EP1356107A2 (en) 2003-10-29
WO2002044417A2 (en) 2002-06-06
ZA200304997B (en) 2004-09-27

Similar Documents

Publication Publication Date Title
HUP0303888A3 (en) Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
AU2002318112B2 (en) Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
SI1576132T1 (sl) Nukleinske kisline z oznako 273p4b7 in njihova uporaba pri odkrivanju raka
GB9925804D0 (en) Biological materials and method useful in the diagnosis and treatment of diseases
HUP0203968A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
EP1517606A4 (en) NUCLEIC ACID AND PROTEIN SUITABLE FOR THE TREATMENT AND DETECTION OF CANCER, DESCRIBED IN 193P1E1B
AU6502199A (en) Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
EP1622571A4 (en) NUCLEIC ACIDS AND CORRESPONDING PROTEINS NAMED 109P1D4 FOR THE TREATMENT AND DETECTION OF CANCER
PT1537140E (pt) Ácido nucleico e proteína correspondente designada 161p2f10b úteis no tratamento e detecção de cancro
AU2002246808A1 (en) Human nucleic acids and polypeptides and methods of use thereof
EP1372719A4 (en) NUCLEIC ACID AND CORRESPONDING PROTEIN WITH THE NAME 125P5C8 FOR THE TREATMENT AND DETECTION OF CANCER
IL155953A0 (en) Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
EP1590437A4 (en) NUCLEIC ACIDS SUITABLE FOR THE TREATMENT AND DETECTION OF CANCER AND CORRESPONDING PROTEINS NAMED 254P1D6B
IL155951A0 (en) Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
HUP0303899A3 (en) Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
EP1539805A4 (en) NUCLEIC ACIDS SUITABLE FOR THE TREATMENT AND DETECTION OF CANCER AND CORRESPONDING PROTEINS NAMED 101P3A11 OR PHOR-1
HK1057237A (en) Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
HK1057907A (en) Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
HK1055997A (en) Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
HK1057238A (en) Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
AU2001286541A1 (en) Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer
GB9917491D0 (en) Biological materials and methods useful in the diagnosis and treastment of diseases
GB9824091D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB0113011D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB0205963D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)